Received Jan 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | T9TL9 | — |
overdose; a one-year-old child received an adult dose of Havrix; This non-serious case was reported by a physician via call center representative and described the occurrence of overdose in a 12-month-old female patient who received HAV (Havrix adult) (batch number T9TL9, expiry date 05-DEC-2025) for prophylaxis. On 08-JAN-2025, the patient received Havrix adult. On 08-JAN-2025, an unknown time after receiving Havrix adult, the patient experienced overdose (Verbatim: overdose) and adult product administered to child (Verbatim: a one-year-old child received an adult dose of Havrix). The outcome of the overdose and adult product administered to child were not applicable. Additional Information: GSK Receipt Date: 07-JAN-2026 The reporter stated that she had received a pediatric dose six months after the adult dose. The batch number was not provided and a request for this information had been made